Infinity Pharmaceuticals, Inc. (INFI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 49.98M |
| Enterprise Value | 12.58M |
| P/E Ratio | -0 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -0 |
| Enterprise/Revenue | 3.79 |
| Enterprise/EBITDA | -0.22 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | June 30, 2023 |
Profitability
| Profit Margin | -17.11 |
| Operating Margin | -17.29 |
AD
Management Effectiveness
| Return On Assets | -1.05 |
| Return On Equity | -35.21 |
Income Statement
| Revenue | 2.59M |
| Revenue/Share | 0.03 |
| Gross Profit | 1.03M |
| EBITDA | -43.73M |
| Net Income | -43.26M |
| Diluted EPS | -0.48 |
Balance Sheet
| Total Cash | 17.75M |
| Total Cash/Share | 0.43 |
| Total Debt | 633,000 |
| Total Debt/Equity | -2.53 |
| Current Ratio | 2.96 |
| Book Value Per Share | -0.21 |
Price History
| 52-Week Change | -99.35 |
| 52-Week High | 1.3 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.09 |
| Moving Average 200 Days | 0.26 |
Statistics
| Average Volume | 3.98M |
| Shares Outstanding | 90.76M |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | September 13, 2006 |
AD
